1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane

C136H174BrN27O12S4 — CID 158244690

IUPAC1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane
SMILESBrc1nccc2ccccc12.C=CC(=O)OC(=O)C=C.S.S.S.S.[C-]#[N+]CC1CCCN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)C1.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)CCN1C(=O)C=C.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)CCN1C(=O)OC(C)(C)C.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCNC3)CCN1C(=O)OC(C)(C)C
InChIInChI=1S/C34H43N7O3.C32H37N7O2.C30H36N6O.C25H38N6O3.C9H6BrN.C6H6O3.4H2S/c1-34(2,3)44-33(42)41-18-17-39(21-26(41)20-35-4)30-19-31(43-23-25-10-8-15-38(25)5)37-29-22-40(16-13-28(29)30)32-27-11-7-6-9-24(27)12-14-36-32;1-4-31(40)39-17-16-37(20-25(39)19-33-2)29-18-30(41-22-24-9-7-14-36(24)3)35-28-21-38(15-12-27(28)29)32-26-10-6-5-8-23(26)11-13-34-32;1-31-18-22-7-5-15-35(19-22)28-17-29(37-21-24-9-6-14-34(24)2)33-27-20-36(16-12-26(27)28)30-25-10-4-3-8-23(25)11-13-32-30;1-25(2,3)34-24(32)31-12-11-30(16-19(31)14-26-4)22-13-23(28-21-15-27-9-8-20(21)22)33-17-18-7-6-10-29(18)5;10-9-8-4-2-1-3-7(8)5-6-11-9;1-3-5(7)9-6(8)4-2;;;;/h6-7,9,11-12,14,19,25-26H,8,10,13,15-18,20-23H2,1-3,5H3;4-6,8,10-11,13,18,24-25H,1,7,9,12,14-17,19-22H2,3H3;3-4,8,10-11,13,17,22,24H,5-7,9,12,14-16,18-21H2,2H3;13,18-19,27H,6-12,14-17H2,1-3,5H3;1-6H;3-4H,1-2H2;4*1H2/t25-,26?;24-,25?;22?,24-;18-,19?;;;;;;/m0000....../s1
InChIKeyGFYYTGDLZDXDCN-HOMZCIKHSA-N
MW2587.24 g/mol
LogP20.02
Rot. Bonds26

About 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane

1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane (PubChem CID 158244690) has the molecular formula C136H174BrN27O12S4 and a molecular weight of 2587.24 g/mol. Its IUPAC name is 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane.

Molecular Properties

Compound Name1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane
PubChem CID158244690
Molecular FormulaC136H174BrN27O12S4
Molecular Weight2587.24 g/mol
Exact Mass2584.19
IUPAC Name1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane
SMILESBrc1nccc2ccccc12.C=CC(=O)OC(=O)C=C.S.S.S.S.[C-]#[N+]CC1CCCN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)C1.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)CCN1C(=O)C=C.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)CCN1C(=O)OC(C)(C)C.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCNC3)CCN1C(=O)OC(C)(C)C
InChIInChI=1S/C34H43N7O3.C32H37N7O2.C30H36N6O.C25H38N6O3.C9H6BrN.C6H6O3.4H2S/c1-34(2,3)44-33(42)41-18-17-39(21-26(41)20-35-4)30-19-31(43-23-25-10-8-15-38(25)5)37-29-22-40(16-13-28(29)30)32-27-11-7-6-9-24(27)12-14-36-32;1-4-31(40)39-17-16-37(20-25(39)19-33-2)29-18-30(41-22-24-9-7-14-36(24)3)35-28-21-38(15-12-27(28)29)32-26-10-6-5-8-23(26)11-13-34-32;1-31-18-22-7-5-15-35(19-22)28-17-29(37-21-24-9-6-14-34(24)2)33-27-20-36(16-12-26(27)28)30-25-10-4-3-8-23(25)11-13-32-30;1-25(2,3)34-24(32)31-12-11-30(16-19(31)14-26-4)22-13-23(28-21-15-27-9-8-20(21)22)33-17-18-7-6-10-29(18)5;10-9-8-4-2-1-3-7(8)5-6-11-9;1-3-5(7)9-6(8)4-2;;;;/h6-7,9,11-12,14,19,25-26H,8,10,13,15-18,20-23H2,1-3,5H3;4-6,8,10-11,13,18,24-25H,1,7,9,12,14-17,19-22H2,3H3;3-4,8,10-11,13,17,22,24H,5-7,9,12,14-16,18-21H2,2H3;13,18-19,27H,6-12,14-17H2,1-3,5H3;1-6H;3-4H,1-2H2;4*1H2/t25-,26?;24-,25?;22?,24-;18-,19?;;;;;;/m0000....../s1
InChIKeyGFYYTGDLZDXDCN-HOMZCIKHSA-N
XLogP20.02
TPSA327.91 Ų
H-Bond Donors1
H-Bond Acceptors32
Rotatable Bonds26
Heavy Atoms180
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002587.24
LogP ≤ 520.02
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane?
The IUPAC name of 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane (CID 158244690) is 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane.
What is the SMILES notation for 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane?
The canonical SMILES for 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane is Brc1nccc2ccccc12.C=CC(=O)OC(=O)C=C.S.S.S.S.[C-]#[N+]CC1CCCN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)C1.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)CCN1C(=O)C=C.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCN(c2nccc4ccccc24)C3)CCN1C(=O)OC(C)(C)C.[C-]#[N+]CC1CN(c2cc(OC[C@@H]3CCCN3C)nc3c2CCNC3)CCN1C(=O)OC(C)(C)C.
What is the InChIKey of 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane?
The InChIKey is GFYYTGDLZDXDCN-HOMZCIKHSA-N. The full InChI is InChI=1S/C34H43N7O3.C32H37N7O2.C30H36N6O.C25H38N6O3.C9H6BrN.C6H6O3.4H2S/c1-34(2,3)44-33(42)41-18-17-39(21-26(41)20-35-4)30-19-31(43-23-25-10-8-15-38(25)5)37-29-22-40(16-13-28(29)30)32-27-11-7-6-9-24(27)12-14-36-32;1-4-31(40)39-17-16-37(20-25(39)19-33-2)29-18-30(41-22-24-9-7-14-36(24)3)35-28-21-38(15-12-27(28)29)32-26-10-6-5-8-23(26)11-13-34-32;1-31-18-22-7-5-15-35(19-22)28-17-29(37-21-24-9-6-14-34(24)2)33-27-20-36(16-12-26(27)28)30-25-10-4-3-8-23(25)11-13-32-30;1-25(2,3)34-24(32)31-12-11-30(16-19(31)14-26-4)22-13-23(28-21-15-27-9-8-20(21)22)33-17-18-7-6-10-29(18)5;10-9-8-4-2-1-3-7(8)5-6-11-9;1-3-5(7)9-6(8)4-2;;;;/h6-7,9,11-12,14,19,25-26H,8,10,13,15-18,20-23H2,1-3,5H3;4-6,8,10-11,13,18,24-25H,1,7,9,12,14-17,19-22H2,3H3;3-4,8,10-11,13,17,22,24H,5-7,9,12,14-16,18-21H2,2H3;13,18-19,27H,6-12,14-17H2,1-3,5H3;1-6H;3-4H,1-2H2;4*1H2/t25-,26?;24-,25?;22?,24-;18-,19?;;;;;;/m0000....../s1.
What are the key properties of 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane?
1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane has a molecular weight of 2587.24 g/mol, XLogP of 20.02, 26 rotatable bonds, 1 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for 1-bromoisoquinoline;tert-butyl 2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;tert-butyl 2-(isocyanomethyl)-4-[2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-5,6,7,8-tetrahydro-1,7-naphthyridin-4-yl]piperazine-1-carboxylate;1-[2-(isocyanomethyl)-4-[7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridin-4-yl]piperazin-1-yl]prop-2-en-1-one;4-[3-(isocyanomethyl)piperidin-1-yl]-7-isoquinolin-1-yl-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-1,7-naphthyridine;prop-2-enoyl prop-2-enoate;sulfane is sourced from PubChem (CID 158244690), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).